Ardelyx stocktwits

Ardelyx, Inc. Biotechnology Fremont, CA 3,550 followers Passionately committed to bettering the lives of patients with kidney and cardiovascular diseases. ARDX - Ardelyx Stock Interactive Chart - Barchart.com Settings. Click the Settings icon to access different options for your chart.. DISPLAY Tab. Bar Type: For each Bar Type, you may customize the color and thickness of the bars. OHLC Bars are drawn to show the open-high-low-close. A vertical line is drawn between the highest and lowest price. The horizontal dash extending to the left of the bar represents the open, and the horizontal dash ARDX: Ardelyx Inc - Price & Consenus Chart - Zacks.com ARDX: Ardelyx Inc - Price and Consensus Chart. Get the latest Price and Consensus Chart for Ardelyx Inc from Zacks Investment Research

Ardelyx Inc. Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of cardiorenal diseases.

Mar 9, 2020 Ardelyx (ARDX) Received its Third Buy in a Row Analyst Chris Shibutani maintained a Buy rating on Ardelyx today. Share on StockTwits. Sep 17, 2019 Ardelyx's long-gestating challenger tenapanor received an FDA approval of its own Thursday under the brand name Ibsrela. Back in 2018 Oct 31, 2019 Ardelyx actively is seeking a partner to market it in the U.S. For Ibsrela's full prescribing information, look here. New Ofev Indication. A new FDA

5 Wall Street analysts have issued ratings and price targets for Ardelyx in the last 12 months. Their average twelve-month price target is $12.00, suggesting that the stock has a possible upside of 73.41%. The high price target for ARDX is $15.00 and the low price target for ARDX is $9.00.

ARDX Stock Quote of Ardelyx Inc Ardelyx (ARDX) Reports Q4 Loss, Tops Revenue Estimates From Zacks Investment Research Mar 6, 2020 Ardelyx (ARDX) delivered earnings and revenue surprises of 17.65% and 221.43%, respectively, for NASDAQ Updated Jun 5, 2020 8:00 PM. 3,621 Watchers. Watch

Read the latest StockTalks, investment ideas, and community discussion on Ardelyx, Inc. (ARDX).

ARDX | Stock Snapshot - Fidelity Jun 08, 2020

Ardelyx, Inc. (ARDX) Latest Stock News & Headlines - Yahoo ...

What happened with Ardelyx? Ardelyx is a small-cap biotech focused on creating therapies for gastro-instestinal and cardiorenal indications. The company's lead compound is tenapanor, a product ARDX Stock Price | Ardelyx Inc. Stock Quote ... - MarketWatch Ardelyx Inc. Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of cardiorenal diseases. Stock Picks, Stock Market Investing | Seeking Alpha Market Data Disclaimer | © 2020 Seeking Alpha